Virgan
1,5 mg/g Ögongel
Previous product name: | |
On the market: | - |
Strength numeric with unit: | |
ATC code: | S01AD09 |
Product type: | Licensläkemedel |
NPL id: | 20130603007879 |
Swedish approval number: | |
Approval number: | |
Marketing authorisation number: | |
Approval date: | |
Authorisation procedure: | Ospecificerad |
OriginID license: | 34009 339 512-8 3 |
Approval country license: | Frankrike |
Dose dispensing: | Nej |
Dose disp. shelf life: | |
Contains lactose: | Ospecificerad |
Contains latex: | Ospecificerad |
Controlled medicinal product: | Nej |
Biological medicinal product: | |
Antimicrobial drug: | Ja |
Narcotic class: | Ej narkotikaklassad |
Prescription drug: | Receptbelagt |
Repeat prescription: | |
Additional monitoring: | Nej |
Dispensing restriction: | |
Human use only: | Nej |
Pharmaceutical product 1:
Ingredient role | Substance | Quantity | Unit | Additional | CAS no. |
---|---|---|---|---|---|
Aktiv beståndsdel | ganciklovir | Angiven mängd är den avsedda, med normal variation | 82410-32-0 |
Company:
Innehavare av godkännande för försäljning: |
---|
Laboratoires THEA, 12 rue Louis Blériot, 63017 Clermont-Ferrand Cedex 2, Frankrike (FR66390813988) |